Global Apheresis Market to Grow at a CAGR of 9.2% During 2024-2032, Driven by the Increasing Prevalence of Lifestyle Related Diseases

Due to the widespread use of plasma therapy in the treatment of COVID-19 affected patients, the apheresis industry is expected to benefit from the COVID-19 pandemic. The apheresis industry is expected to grow in the forecast period owing to the widespread use of apheresis units in the care of COVID-19 patients and rising FDA approvals. The increasing R&D activities by the leading pharmaceutical corporations such as Pfizer Inc. (NYSE: PFE) and Moderna Inc (NASDAQ: MRNA) to develop COVID-19 vaccines are also driving the industry growth. In addition to this, the increasing number of lifestyle related diseases and hospitalisation rates, a rise in demand for blood components and associated protection, technical advances in the implementation of modern apheresis techniques, and an increase in reimbursement policies and financing for apheresis procedures are expected to significantly contribute to the apheresis industry growth.

Apheresis is increasingly being used in clinically sick patients as a primary medication or as a supplement to other drugs for a variety of disorders, including thrombotic thrombocytopenic purpura, haemolytic uremic syndrome, opioid toxicity, autoimmune disorder, sepsis, and fulminant hepatic failure. The apheresis industry for haematological disorders is projected to rise in the forecast era, owing to rising haematological incidences and the applications of apheresis as a treatment tool for haematological disorders. In recent years, novel therapeutic apheresis options such as immunoadsorption, double filtration, and cytapheresis have been available for the treatment of both primary and secondary autoimmune renal diseases. The involvement of most of the major players in the area, as well as increasing product approvals, play a key role in the market's development. Fresenius SE & Co. KGaA (ETR: FRE), a healthcare company based in Germany invested € 30 million in a project for transfusion and apheresis disposables in the Dominican Republic. Such developments have significantly contributed to the industry growth.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Analysis by Product, Technology, Procedure, Application, and Region:

• The market on the basis of product can be divided into devices and disposables.

• Based on technology, the industry can be divided into centrifugation and membrane separation.

• The different procedures for apheresis include plasmapheresis, leukaepheresis, erythrocytapheresis, and plateletpheresis, among others.

• Based on application, the market is categorised into renal diseases, haematological diseases, autoimmune diseases, and neurological diseases, among others.

• The regional markets for apheresis include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

• The growing demand for various blood components, the complexity of surgical operations, and an increase in the number of injuries around the world have all led to the market's expansion.

• The emerging regions like the Asia Pacific are expected to provide enhanced growth opportunities to the industry owing to the improving healthcare facilities in countries like India and China. 

• The rising prevalence of leukaemia has been a major reason for the growth of this market.

• The favourable government initiatives to raise awareness on voluntary blood donation and public health are likely to aid the market growth.

Key Offerings of the Report:

• The EMR report gives an overview of the global market for apheresis for the periods (2018-2023) and (2024-2032).

• The report also offers the historical (2018-2023) and forecast (2024-2032) markets for the products, technologies, procedures, applications, and regions of apheresis.

• The report analyses the market dynamics, covering the key demand and price indicators in the market, along with an assessment of the SWOT and Porter’s Five Forces models.

The major players in the global apheresis market are Nikkiso Co., Ltd., Asahi Kasei Medical Co. Ltd, B. Braun Melsungen AG, Fresenius SE & Co. KGaA, and Terumo Bct, Inc, among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.

About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us:

Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.